PharMerica Corporation provides long term care pharmacy services in the United States.

According to the Complaint, on August 1, 2017, PharMerica’s Board of Directors caused the Company to enter into an agreement and plan of merger with affiliates of Kohlberg Kravis Roberts & Co. L.P.

On September 6, 2017, in order to convince PharMerica shareholders to vote in favor of the Proposed Merger, the Complaint alleges the Board authorized the filing of a materially incomplete and misleading Preliminary Proxy Statement on a Schedule 14A with the Securities and Exchange Commission, in violation of Sections 14(a) and 20(a) of the Exchange Act.

This case was voluntarily dismissed as moot on December 1, 2017.